Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

New effective scar treatments are urgently needed due to the current options' limited success.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

New understanding and treatments for hair loss are improving, but more research is needed.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Retinoids may help treat lupus nephritis and reduce steroid use.

Karunjchirakam Chooranam significantly improved symptoms in most PCOS cases.